2019-11-12 08:11:03 | Amarin soars after FDA posts briefing docs ahead of Nov. 14 panelShares of Amarin are jumping after the FDA posted its briefing documents for the panel meeting on Vascepa's label expansion to be held on November 14. Shares of Amarin are up 13%, or $2.24, to $19.15 in premarket trading. | |
---|